share_log

Zymeworks Reports Preliminary Phase 1 Trial Results For Zanidatamab Zovodotin (ZW49) At European Society For Medical Oncology Annual Congress; Co To Host Conference Call, Webcast At 4:30 P.m. EDT Today

Zymeworks Reports Preliminary Phase 1 Trial Results For Zanidatamab Zovodotin (ZW49) At European Society For Medical Oncology Annual Congress; Co To Host Conference Call, Webcast At 4:30 P.m. EDT Today

Zymeworks在欧洲医学肿瘤学会年会上报告了Zanidatamab Zovodotin(ZW49)的初步第一阶段试验结果;联合主持电话会议,下午4:30网络直播。今日美国东部夏令时
Benzinga Real-time News ·  2022/09/12 16:16

Zymeworks Reports Preliminary Phase 1 Trial Results For Zanidatamab Zovodotin (ZW49) At European Society For Medical Oncology Annual Congress; Co To Host Conference Call, Webcast At 4:30 p.m. EDT Today

Zymeworks在欧洲医学肿瘤学会年会上报告了Zanidatamab Zovodotin(ZW49)的初步第一阶段试验结果;联合主持电话会议,下午4:30网络直播。今日美国东部夏令时

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发